Skip to main content

Table 2 Laboratory findings of the study groups

From: Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasound technique

 

Group I (n = 271)

Group II (n = 170)

Group III (n = 217)

Haemoglobin, g/dL

   

  Prebiopsy

12.7 ± 2.3

12.7 ± 3.2

12.7 ± 2.2

  Postbiopsy

12.3 ± 2.3

12.3 ± 2.5

12.5 ± 2.4

  ΔHaemoglobin

0.3 ± 1.2

0.4 ± 2.3

0.1 ± 1.4

Haematocrit, %

   

  Prebiopsy

36.8 ± 6.8

37.3 ± 6.9

37.3 ± 6.2

  Postbiopsy

35.9 ± 6.6

36.6 ± 7.3

36.8 ± 6.2

  ΔHaematocrit

0.5 ± 4.3

0.7 ± 2.6

0.5 ± 2.5

Platelet count, x103/mm3

247 ± 78

234 ± 69a

252 ± 72

INR

0.94 ± 0.10b

0.97 ± 0.09

0.99 ± 0.09

BUN, mg/dL

21.9 ± 17.3c

20.5 ± 12.8

18.0 ± 11.7

Serum creatinine, mg/dL

  Mean ± SD

1.46 ± 1.33

1.47 ± 1.38

1.25 ± 1.17

  Range

0.56-10.64

0.58-11.21

0.36-9.60

eGFR, mL/min/1.73 m2

74.07 ± 31.86

73.67 ± 32.41

83.56 ± 35.26d

24 hr Proteinuria, g/day

1.57 (0.30-4.50)e

0.86 (0.18-2.76)

1.43 (0.26-3.46)

  1. Data are presented as mean ± standard deviation, range or median (interquartile interquartile, IQR).
  2. aGroup II versus Groups III, p = 0.0425.
  3. bGroup I versus Group II, p = 0.0028 and Group I versus Group III, p < 0.0001
  4. cGroup I versus III, p = 0.0102.
  5. dGroup III versus Group I, p = 0.0053 and Group III versus Group II, p = 0.0111
  6. eGroup I versus Group II, p = 0.0079 and Group I versus Group III, p = 0.0060.
  7. INR, international normalized ratio, BUN, blood urea nitrogen, SD, standard deviation, eGFR, estimated glomerular filtration rate.